Literature DB >> 35978695

Therapeutic and Effective CURE-PRO Molecules for E3 Ligase-Mediated Targeted Protein Degradation.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2022        PMID： 35978695      PMCID： PMC9377323          DOI： 10.1021/acsmedchemlett.2c00315

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.

Authors:  Yihui Song; Shu Wang; Min Zhao; Xinyu Yang; Bin Yu
Journal:  J Med Chem       Date:  2022-02-14       Impact factor: 7.446

Review 2.  Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.

Authors:  Lu Feng; Guan Wang; Yi Chen; Gu He; Bo Liu; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  Med Res Rev       Date:  2021-10-11       Impact factor: 12.944

3.  Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development.

Authors:  Juncheng Chen; Pan Tang; Yuxi Wang; Jiaxing Wang; Chengcan Yang; Yang Li; Gaoxia Yang; Fengbo Wu; Jifa Zhang; Liang Ouyang
Journal:  J Med Chem       Date:  2022-03-24       Impact factor: 7.446

Review 4.  Clinical considerations for the design of PROTACs in cancer.

Authors:  Cristina Nieto-Jiménez; Esther Cabañas Morafraile; Carlos Alonso-Moreno; Alberto Ocaña
Journal:  Mol Cancer       Date:  2022-03-07       Impact factor: 27.401

Review 5.  Advances in targeted therapy in non-small cell lung cancer with actionable mutations and leptomeningeal metastasis.

Authors:  Ding Li; Zhenguo Song; Bingqi Dong; Wenping Song; Cheng Cheng; Yongna Zhang; Wenzhou Zhang
Journal:  J Clin Pharm Ther       Date:  2021-07-26       Impact factor: 2.512

Review 6.  PROTAC targeted protein degraders: the past is prologue.

Authors:  Miklós Békés; David R Langley; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2022-01-18       Impact factor: 112.288
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.